The FDA announced on May 13, 2025, that Zydus Pharmaceuticals (USA) Inc is recalling Esomeprazole Magnesium for Delayed-Release Oral Suspension due to failed impurity specifications. The agency stated the recall addresses out-of-specification test results for unknown degradation products.
How to tell if you have it
- Brand: Zydus
- Product: Esomeprazole Magnesium 20 mg
- NDC: 68382-848-94
- Lot M402147, Exp 10/2025
- Lot M311637, Exp 07/2025
- Lot M402495, Exp 02/2026
- Lot M407997, Exp 05/2026
- Lot M502246, Exp11/2026
The hazard
The recall addresses failed impurities and degradation specifications. Specifically, out-of-specification test results were obtained for any individual unknown degradation product during Related Compounds testing during long term stability.
Context
GovInfoNow's records show Zydus Pharmaceuticals (USA) Inc has 53 other recalls on record since 2012-03-14. Other recent recalls of similar products include Zydus Mirabegron 25mg Tablets Recall (2026-08-05), Zydus Erythromycin Tablets Recall (2026-04-29), and Zydus Recalls Icosapent Ethyl Capsules Due to Defects (2026-03-09). Other recent recalls of similar products include Rising Pharma Recalls Temozolomide 5mg Capsules Due to Impurity Issues (2026-03-03), Novadoz Glycopyrrolate Oral Solution Recall (2025-12-15), and Somerset Therapeutics Dexamethasone Injection Recall (2026-02-04).